月经周期中激素变化对神经系统疾病影响的研究进展
Research Advances in Effects of Hormonal Changes during the Menstrual Cycle on Neu-rological Diseases
DOI: 10.12677/ACM.2022.12111487, PDF,   
作者: 程玉莹, 赵育周, 杨丹丹, 赵含之, 刘 梦：西安医学院，陕西 西安；邸 伟*：西安医学院，陕西 西安；陕西省人民医院，陕西 西安
关键词: 月经周期；雌激素；孕激素；神经系统疾病；Menstrual Cycle； Estrogen； Progesterone； Nervous System Disease
摘要: 月经是女性进入青春期后，子宫内膜受卵巢激素的影响，出现周期性子宫出血，月经的周期性变化被称为月经周期。月经周期中激素水平波动对神经系统的疾病发生或进展有一定影响，其中包括偏头痛/癫痫/多发性硬化症/帕金森综合征等神经系统疾病。有研究已经确定了月经周期中激素变化与神经系统疾病发生与发展的一些机制，目前在中枢神经系统疾病中也发现了月经周期中激素异常与该疾病的发生及发展是相关的，本文拟就月经周期中激素变化对中枢神经系统疾病影响的相关进展进行综述。
Abstract: After the female enters puberty, the endometrium is affected by ovarian hormones, and there is pe-riodic uterine bleeding, called menstruation, and the periodic change of menstruation is called the menstrual cycle. Fluctuations in hormone levels during the menstrual cycle affect the development or progression of neurological disorders, including migraine/epilepsy/multiple sclero-sis/Parkinson’s syndrome. Studies have identified some of the mechanisms by which hormonal changes during the menstrual cycle are linked to the development and progression of neurological diseases. Hormonal abnormalities in the menstrual cycle have also been found to be associated with the occurrence and development of central nervous system diseases. This study aims to review the recent advances in the effects of hormonal changes during menstrual cycle on central nervous sys-tem diseases.
文章引用：程玉莹, 赵育周, 杨丹丹, 赵含之, 刘梦, 邸伟. 月经周期中激素变化对神经系统疾病影响的研究进展[J]. 临床医学进展, 2022, 12(11): 10312-10317. https://doi.org/10.12677/ACM.2022.12111487

参考文献

[1] Messinis, I.E., Messini, C.I. and Dafopoulos, K. (2014) Novel Aspects of the Endocrinology of the Menstrual Cycle. Reproductive BioMedicine Online, 28, 714-722. [Google Scholar] [CrossRef] [PubMed]
[2] Limonta, P., Ma-relli, M.M., Moretti, R., Marzagalli, M., Fontana, F. and Maggi, R. (2018) GnRH in the Human Female Reproductive Axis. Vitamins and Hormones, 107, 27-66. [Google Scholar] [CrossRef] [PubMed]
[3] Abo, S., Smith, D., Stadt, M. and Layton, A. (2022) Modelling Female Physiology from Head to Toe: Impact of Sex Hormones, Menstrual Cycle, and Pregnancy. Journal of Theoretical Biology, 540, Article ID: 111074. [Google Scholar] [CrossRef] [PubMed]
[4] Bernal, A. and Paolieri, D. (2022) The Influence of Estradiol and Progesterone on Neurocognition during Three Phases of the Menstrual Cycle: Modulating Factors. Behavioural Brain Research, 417, Article ID: 113593. [Google Scholar] [CrossRef] [PubMed]
[5] Spierings, E.L. and Padamsee, A. (2015) Menstrual-Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study. Pain Medicine, 16, 1426-1432. [Google Scholar] [CrossRef] [PubMed]
[6] Moscol, G., Espino, P.H., Mayor, L.C. and Burneo, J.G. (2022) Epilepsy with Catamenial Pattern. Revue Neurologique, 74, 303-311.
[7] Buse, D.C., Loder, E.W., Gorman, J.A., Stewart, W.F., Reed, M.L., Fanning, K.M., Serrano, D. and Lipton, R.B. (2013) Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 53, 1278-1299. [Google Scholar] [CrossRef] [PubMed]
[8] Ahmad, S.R. and Rosendale, N. (2022) Sex and Gender Considerations in Episodic Migraine. Current Pain and Headache Reports, 26, 505-516. [Google Scholar] [CrossRef] [PubMed]
[9] 唐钰莎, 陈蕾, 何时旭, 宋婷婷. 基于fMRI探究月经周期与无先兆偏头痛相关性[J]. 医学研究杂志, 2022, 51(4): 54-58.
[10] Allais, G., Chiarle, G., Sinigaglia, S., Airola, G., Schiapparelli, P. and Benedetto, C. (2020) Gender-Related Differences in Migraine. Neurological Sciences, 41, 429-436. [Google Scholar] [CrossRef] [PubMed]
[11] Maasumi, K., Tepper, S.J. and Kriegler, J.S. (2017) Menstrual Migraine and Treatment Options: Review. Headache, 57, 194-208. [Google Scholar] [CrossRef] [PubMed]
[12] Nappi, R.E., Tiranini, L., Sacco, S., De Matteis, E., De Icco, R. and Tassorelli, C. (2022) Role of Estrogens in Menstrual Mi-graine. Cells, 11, Article No. 1355. [Google Scholar] [CrossRef] [PubMed]
[13] 赖小燕, 胡幼平, 艾虹静, 王卓慧, 张琪, 吴双, 兰蕾. 雌激素对偏头痛的影响及机制[J]. 中国疼痛医学杂志, 2016, 22(11): 851-853.
[14] Petrovski, B., Vetvik, K.G., Lundqvist, C. and Eberhard-Gran, M. (2018) Characteristics of Menstrual versus Non- Menstrual Mi-graine during Pregnancy: A Longitudinal Population-Based Study. The Journal of Headache and Pain, 19, 27-33. [Google Scholar] [CrossRef] [PubMed]
[15] Calhoun, A. (2012) Combined Hormonal Contraceptives: Is It Time to Reassess Their Role in Migraine? Headache, 52, 648-660. [Google Scholar] [CrossRef] [PubMed]
[16] Warhurst, S., Rofe, C.J., Brew, B.J., Bateson, D., McGee-chan, K., Merki-Feld, G.S., Garrick, R. and Tomlinson, S.E. (2018) Effectiveness of the Progestin-Only Pill for Migraine Treatment in Women: A Systematic Review and Meta-Analysis. Cephalalgia, 38, 754-764. [Google Scholar] [CrossRef] [PubMed]
[17] Amandusson, Å. and Blomqvist, A. (2013) Estrogenic Influences in Pain Processing. Frontiers in Neuroendocrinology, 34, 329-349. [Google Scholar] [CrossRef] [PubMed]
[18] Gu, P., Chen, C., Wu, Q., Dong, C., Wang, T., Wan, Q. and Dong, X. (2021) The Effect and Safety of 5-HT(1F) Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Me-ta-Analysis. BioMed Research International, 2021, Article ID: 6663591. [Google Scholar] [CrossRef] [PubMed]
[19] Charbit, A.R., Akerman, S. and Goadsby, P.J. (2010) Dopamine: What’s New in Migraine? Current Opinion in Neurology, 23, 275-281. [Google Scholar] [CrossRef] 
[20] de Vries, T., Villalón, C.M. and Maassen Van Den Brink, A. (2020) Pharmacological Treatment of Migraine: CGRP and 5-HT beyond the Triptans. Pharmacology & Therapeutics, 211, Article ID: 107528. [Google Scholar] [CrossRef] [PubMed]
[21] Peters, G.L. (2019) Migraine Overview and Summary of Current and Emerging Treatment Options. The American Journal of Managed Care, 25, S23-S34.
[22] Ha, H. and Gonzalez, A. (2019) Migraine Headache Prophylaxis. American Family Physician, 99, 17-24.
[23] Burch, R. (2020) Epidemiology and Treatment of Menstrual Migraine and Migraine during Pregnancy and Lactation: A Narrative Review. Headache, 60, 200-216. [Google Scholar] [CrossRef] [PubMed]
[24] Johansson, T., Fowler, P., Ek, W.E., Skalkidou, A., Karlsson, T. and Johansson, Å. (2022) Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk. Stroke, 53, 3107-3115. [Google Scholar] [CrossRef] 
[25] 吴海燕. 月经相关性癫痫的发病机制及治疗研究进展[J]. 癫痫与神经电生理学杂志, 2018, 27(6): 373-377.
[26] 王湘庆. 女性癫(痫)临床研究进展解读[J]. 中国现代神经疾病杂志, 2018, 18(5): 310-314.
[27] Bosak, M., Słowik, A. and Turaj, W. (2018) Menstrual Disorders and Their Determinants among Women with Epilepsy. Neuropsychiatric Disease and Treatment, 14, 2657-2664. [Google Scholar] [CrossRef] 
[28] Taubøll, E., Isojärvi, J.I.T. and Herzog, A.G. (2021) The Interactions between Reproductive Hormones and Epilepsy. Handbook of Clinical Neurology, 182, 155-174. [Google Scholar] [CrossRef] 
[29] Joshi, S., Sun, H., Rajasekaran, K., Williamson, J., Pe-rez-Reyes, E. and Kapur, J. (2018) A Novel Therapeutic Approach for Treatment of Catamenial Epilepsy. Neurobiology of Disease, 111, 127-137. [Google Scholar] [CrossRef] [PubMed]
[30] Simpkins, J.W., Singh, M., Brock, C. and Etgen, A.M. (2012) Neuroprotection and Estrogen Receptors. Neuroendocrinology, 96, 119-130. [Google Scholar] [CrossRef] [PubMed]
[31] Maguire, M.J. and Nevitt, S.J. (2021) Treatments for Seizures in Catame-nial (Menstrual-Related) Epilepsy. Cochrane Database of Systematic Reviews, 9, Cd013225. [Google Scholar] [CrossRef] 
[32] Oh, J., Vidal-Jordana, A. and Montalban, X. (2018) Mul-tiple Sclerosis: Clinical Aspects. Current Opinion in Neurology, 31, 752-759. [Google Scholar] [CrossRef] 
[33] Mirmosayyeb, O., Badihian, S., Manouchehri, N., Basiri, A.K., Barzegar, M., Esmaeil, N., Fayyazi, E. and Shaygannejad, V. (2018) The Interplay of Multiple Sclerosis and Men-strual Cycle: Which One Affects the Other One? Multiple Sclerosis and Related Disorders, 21, 46-50. [Google Scholar] [CrossRef] [PubMed]
[34] Pozzilli, C. and Pugliatti, M. (2015) An Overview of Pregnan-cy-Related Issues in Patients with Multiple Sclerosis. European Journal of Neurology, 22, 34-39. [Google Scholar] [CrossRef] [PubMed]
[35] Nabavi, S.M., Koupai, S.A., Nejati, M.R., Garshasbi, E. and Jalali, M.R. (2010) Menstrual Irregularities and Related Plasma Hormone Levels in Multiple Sclerosis Patients Treated with Beta In-terferone. Acta Medica Iranica, 48, 36-41.
[36] Veenman, L. (2020) Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start. International Journal of Molecular Sciences, 21, Article No. 7586. [Google Scholar] [CrossRef] [PubMed]
[37] Cerri, S., Mus, L. and Blandini, F. (2019) Parkinson’s Disease in Women and Men: What’s the Difference? Journal of Parkinson’s Disease, 9, 501-515. [Google Scholar] [CrossRef] 
[38] Lee, Y.H., Cha, J., Chung, S.J., Yoo, H.S., Sohn, Y.H., Ye, B.S. and Lee, P.H. (2019) Beneficial Effect of Estrogen on Nigrostriatal Dopaminergic Neurons in Drug-Naïve Postmenopausal Parkinson’s Disease. Scientific Reports, 9, Article No. 10531. [Google Scholar] [CrossRef] [PubMed]
[39] Song, Y.J., Li, S.R., Li, X.W., Chen, X., Wei, Z.X., Liu, Q.S. and Cheng, Y. (2020) The Effect of Estrogen Replacement Therapy on Alzheimer’s Disease and Parkinson’s Disease in Postmenopausal Women: A Meta-Analysis. Frontiers in Neuroscience, 14, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
[40] Bourque, M., Morissette, M. and Di Paolo, T. (2019) Repurposing Sex Steroids and Related Drugs as Potential Treatment for Parkinson’s Disease. Neuropharmacology, 147, 37-54. [Google Scholar] [CrossRef] [PubMed]

为你推荐